Tight blood glucose control with insulin in the ICU - Facts and controversies
ABSTRACT Recently, the concept that stress hyperglycemia in critically ill patients is an adaptive, beneficial response has been challenged. Two large randomized studies demonstrated that maintenance of normoglycemia with intensive insulin therapy substantially prevents morbidity and reduces mortality in these patients. Since then, questions have been raised about the efficacy in general and in specific subgroups, and about the safety of this therapy with regard to potential harm of brief hypoglycemic episodes and of high-dose insulin administration. These issues are systematically addressed in relation to the available evidence. Intensive insulin therapy during intensive care is effective in reducing the mortality and morbidity of critical illness. The available randomized studies show that an absolute reduction in risk of hospital death of 3 to 4% is to be expected from this therapy in an intention-to-treat analysis. In order to confirm this survival benefit and assign it as statistically significant, future studies should be adequately powered, and hence sample size should be at least 5,000. The absolute reduction in the risk of death increases to approximately 8% when patients are treated with intensive insulin for at least 3 days. Data available thus far indicate that blood glucose control to strict normoglycemia is required to obtain the most clinical benefit. The risk of hypoglycemia increases with this therapy, but it remains unclear whether this is truly harmful in the setting of critical care.
- SourceAvailable from: Karen Choong
Chapter: Hormonal Therapies in Severe SepsisSevere Sepsis and Septic Shock - Understanding a Serious Killer, 02/2012; , ISBN: 978-953-307-950-9
- [Show abstract] [Hide abstract]
ABSTRACT: Necrotizing pancreatitis is a severe disease characterized by gland necrosis and a destructive systemic inflammatory response. Early management involves aggressive resuscitative and supportive measures. Outcomes are primarily determined by the presence of late secondary bacterial infection of the necrotic gland. Early empiric antibiotics and late surgical necrosectomy in the appropriate setting are the keys to managing these sick patients. With appropriate management, mortality can be minimized and long-term quality of life may be restored.Surgical Clinics of North America 01/2008; 87(6):1431-46, ix. DOI:10.1016/j.suc.2007.08.013 · 1.93 Impact Factor
Article: The review panel had some reservations about these guidelines, and similar comments became apparent also in the open presentation at the Florence Congress. Section 1.10 is felt to have reviewed the literature in such a way as to produce a controversial conclusion that is not well supproted by data or by usual clinical practice in most centres. It is proposed that the conclusions and recommendations of this section are amended to avoid recommending prolonged starvation